Nanalysis Scientific Corp. (TSXV:NSCI)
0.1250
0.00 (0.00%)
At close: Jul 31, 2026
Nanalysis Scientific Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17 | 22 | 36 | 38 | 69 | 112 | |
Market Cap Growth | -35.86% | -37.92% | -5.20% | -44.57% | -38.38% | 256.71% |
Enterprise Value | 31.44 | 39.53 | 53.22 | 59.43 | 88.62 | 107.47 |
Last Close Price | 0.13 | 0.17 | 0.32 | 0.38 | 0.73 | 1.45 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 13.89 | 4.40 | 15.00 | 15.00 | 18.25 | 72.50 |
PS Ratio | 0.43 | 0.56 | 0.80 | 1.34 | 2.78 | 6.97 |
PB Ratio | 1.34 | 1.68 | 2.33 | 1.63 | 1.96 | 4.67 |
P/TBV Ratio | - | - | - | 20.22 | - | 10.78 |
P/FCF Ratio | 45.91 | 7.10 | 11.30 | - | - | - |
P/OCF Ratio | 26.96 | 6.52 | 11.10 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.78 | 0.98 | 1.17 | 2.09 | 3.57 | 6.70 |
EV/EBITDA Ratio | - | - | - | - | - | 129.33 |
EV/FCF Ratio | 83.41 | 12.47 | 16.59 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.73 | 0.73 | 0.92 | 0.75 | 0.19 | 0.16 |
Debt / EBITDA Ratio | - | - | - | - | - | 7.20 |
Debt / FCF Ratio | 39.44 | 5.55 | 5.73 | - | - | - |
Net Debt / Equity Ratio | 1.09 | 1.27 | 1.09 | 0.90 | 0.21 | -0.18 |
Net Debt / EBITDA Ratio | -76.42 | -50.24 | -2.76 | -2.40 | -1.31 | -5.32 |
Net Debt / FCF Ratio | 37.50 | 5.37 | 5.30 | -1.78 | -0.68 | 2.46 |
Asset Turnover | 1.10 | 0.99 | 0.95 | 0.46 | 0.46 | 0.52 |
Inventory Turnover | 1.45 | 1.43 | 1.81 | 1.46 | 2.00 | 1.78 |
Quick Ratio | 0.66 | 0.53 | 0.87 | 0.72 | 0.93 | 1.91 |
Current Ratio | 1.02 | 0.97 | 1.27 | 1.23 | 1.63 | 2.40 |
Return on Equity (ROE) | -42.72% | -39.07% | -69.76% | -47.24% | -27.72% | -9.25% |
Return on Assets (ROA) | -9.83% | -9.36% | -22.36% | -21.79% | -17.99% | -5.62% |
Return on Invested Capital (ROIC) | -12.55% | -12.00% | -27.85% | -27.10% | -26.06% | -10.06% |
Return on Capital Employed (ROCE) | -16.97% | -15.31% | -32.05% | -28.21% | -23.75% | -7.31% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | 2.18% | 14.09% | 8.85% | - | - | - |
Buyback Yield / Dilution | -6.62% | -3.68% | -11.56% | -7.25% | -31.35% | -7.77% |
Total Shareholder Return | -6.62% | -3.68% | -11.56% | -7.25% | -31.35% | -7.77% |